Hereditary breast cancer and ovarian cancer

Hereditary breast cancer and ovarian cancer: Clinical course and treatment

Research output: Contribution to journal › Article › peer-review

Department of Oncology

DOI

https://doi.org/10.17650/1994-4098-2020-16-4-54-65
Final published version

V. V. Semiglazov
A. E. Protasova
G. K. Kalikeev

This article analyzes current problems associated with surgical and systemic treatment for hereditary breast and ovarian cancers (including those associated with BRCA1/2 gene mutations). We discuss the issues related to clinical course of multiple primary tumors and their sensitivity to cytostatic and targeted therapy.

Original language	English
Pages (from-to)	54-65
Number of pages	12
Journal	Opuholi Zenskoj Reproduktivnoj Sistemy
Volume	16
Issue number	4
DOIs	https://doi.org/10.17650/1994-4098-2020-16-4-54-65
State	Published - 2020

Research areas

BRCA1, BRCA2, Breast cancer, CHEK2, Multiple primary tumors, Ovarian cancer, PARP inhibitors

Scopus subject areas

Obstetrics and Gynecology
Oncology
Pharmacology (medical)
Radiology Nuclear Medicine and imaging
Surgery

ID: 88554169